Cargando…
The mitochondrial citrate carrier, SLC25A1, drives stemness and therapy resistance in non-small cell lung cancer
Therapy resistance represents a clinical challenge for advanced non-small cell lung cancer (NSCLC), which still remains an incurable disease. There is growing evidence that cancer-initiating or cancer stem cells (CSCs) provide a reservoir of slow-growing dormant populations of cells with tumor-initi...
Autores principales: | Fernandez, Harvey R., Gadre, Shreyas M., Tan, Mingjun, Graham, Garrett T., Mosaoa, Rami, Ongkeko, Martin S., Kim, Kyu Ah, Riggins, Rebecca B., Parasido, Erika, Petrini, Iacopo, Pacini, Simone, Cheema, Amrita, Varghese, Rency, Ressom, Habtom W, Zhang, Yuwen, Albanese, Christopher, Üren, Aykut, Paige, Mikell, Giaccone, Giuseppe, Avantaggiati, Maria Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6030199/ https://www.ncbi.nlm.nih.gov/pubmed/29651165 http://dx.doi.org/10.1038/s41418-018-0101-z |
Ejemplares similares
-
Inhibition of the mitochondrial citrate carrier, Slc25a1, reverts steatosis, glucose intolerance, and inflammation in preclinical models of NAFLD/NASH
por: Tan, Mingjun, et al.
Publicado: (2020) -
Using a spike-in experiment to evaluate analysis of LC-MS data
por: Tuli, Leepika, et al.
Publicado: (2012) -
The Mitochondrial Citrate Carrier SLC25A1/CIC and the Fundamental Role of Citrate in Cancer, Inflammation and Beyond
por: Mosaoa, Rami, et al.
Publicado: (2021) -
Biomarker Discovery for Hepatocellular Carcinoma in Patients with Liver Cirrhosis Using Untargeted Metabolomics and Lipidomics Studies
por: Rashid, Md Mamunur, et al.
Publicado: (2023) -
Ion annotation-assisted analysis of LC-MS based metabolomic experiment
por: Varghese, Rency S, et al.
Publicado: (2012)